Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122393) titled 'Construction of a Specialized Cohort for Immunotherapy in Nasopharyngeal Carcinoma' on April 13.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Affiliated Hospital of Guangdong Medical University
Condition:
Nasopharyngeal carcinoma
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2025-04-09
Target Sample Size: Nasopharyngeal carcinoma patients diagnosed by pathology and undergoing immunotherapy.:500;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=316350
Published by HT Digital Content Services with per...